top of page
Search
Could Psychedelic Therapies Offer New Hope for Alzheimer's Disease?
Alzheimer’s Disease (AD) is a pressing global challenge, with cases expected to triple globally, affecting around 152 million people by...
Mar 29
Research: Psilocybin Microdosing Boosts Emotional Stability and Reduces Depression and Anxiety Symptoms.
The global burden of mental health disorders is rising, with depression and anxiety leading the charge as major contributors to...
Feb 7
The Psychedelic Mushroom Market is Set to Double in the Next 5 Years
The global psychedelic mushroom market is on a trajectory of unprecedented growth. According to a recent report by Persistence Market...
Jan 31
French Microdosing Startup Mabel Raises €600K to Launch Psychedelic-Based Women’s Health Platform
Mabel , a Paris-based women’s health startup, has officially launched following two years of research and development and a €600K...
Jan 5
Psilocybin Research: A New Era in Alcohol Addiction Treatment?
Treating alcohol use disorder (AUD) is one of the most challenging tasks in modern medicine, with high relapse rates and varied patient...
Dec 13, 2024
bottom of page